BJDX Bluejay Diagnostics, Inc.
$0.90▼ -11.16%
Healthcare
Other
After hours
$0.86▼ -4.54%
Sep 11, 7:57 PM ET
Volume 305.9K
Avg Volume (10D) 6.07M
Key Metrics & Fundamentals
Market Cap
$928,449
P/E Ratio
–
Div Yield
–%
52W Range
0.82 - 16.68
% vs 50 MA
-5.44%
% vs 200 MA
-57.57%
RSI-14
49.2
MACD Histogram
+0.0400
Beta (1Y vs SPY)
0.72
Free Cash Flow
-$1.64M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$2.30M
COGS
–
Operating Exp
$2.35M
Operating Income
-$2.35M
EBIT
-$2.35M
Pretax Income
-$2.32M
Net Income
-$2.32M
EPS (Diluted)
-1.12
Price & Volume History
Loading chart…
Recent News
Bluejay Diagnostics Federal Healthcare Partnership Builds Commercial Pathway Ahead of FDA Clearance
InvestorsHub · Sep 8, 2026 2:55 PM
BC-Most Active Stocks
Associated Press · Sep 8, 2026 2:30 PM
Bluejay Diagnostics and Lovell Government Services Announce Partnership to Expand Access to U.S. Federal Healthcare Markets
GlobeNewswire · Sep 8, 2026 10:30 AM
Bluejay Diagnostics Reports Q2 2026 Results; Strengthened Balance Sheet Supports Advancement of Symphony™ IL-6 Toward Regulatory Submission and Commercialization
GlobeNewswire · Aug 13, 2026 10:00 AM
Top Premarket Gainers
MT Newswires · Aug 5, 2026 11:26 AM
Bluejay Diagnostics Completes Enrollment in SYMON-II Clinical Validation Study
MT Newswires · Jul 21, 2026 11:32 AM
Bluejay Diagnostics Announces Successful Completion of Enrollment in the SYMON-II Multicenter Clinical Validation Study
GlobeNewswire · Jul 21, 2026 10:30 AM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See BJDX's money flow as a full page
Social Sentiment
Avg -0.60 · 1 posts
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.